Q21LZ9 AF NFT

Glucokinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig5wyuhbqsbxp7cuiv2shtde3xuw5umkmihpadxfzyq6mj7hach7i/metadata.json
IPFS of structure file: 
bafybeifrzhknxoncpgfptcsm3gd3ht4tndchkuhruec7r2ri3p5gqatd6a/AF-Q21LZ9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5998bFB2F22991b222F61c8c1535024ca911B6b8
First NFT owner address (bech32): 
genesis1txvtlvhj9xgmyghkrjxp2dgzfj53rd4cz33v7q
Current NFT ID #149241 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
149241
Accession (UniProt):
Q21LZ9
Name::
Glucokinase
Experimental Method:
Predicted structure
Sequence source:
Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q21LZ9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q21LZ9|GLK_SACD2 Glucokinase OS=Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024) OX=203122 GN=glk PE=3 SV=1 MFMYPYIVADIGGTNARFALVTGKKGNAFNLEQIQILNGSEFPRLQDAMQHYIDTLGGEKPKAACVAIAGPIDGDNARMTNLNWEFSQAAVKAEFGFDKYDTLNDFGALAVATSSLQADNLIEIKAGTMDPKGNKAILGPGTGLGVAGLACAGDSWLPIPSEGGHVNVAPATQLECEVIRAAMAEHGHVSAETFISGPGLVRLYRALATVRGETPKNYEPKDITAGALDGTDDLCKETLDLFCSFIGSLSGNLALTYGAKGGVYLAGGVLPRFIDYFKSSDFVKRFSEKGVMSHYVENIPVNLISYEYTAFVGAAAWLDQL